Grafting vs Intraoperative Mitomycin C for Preventing Pterygium Recurrence: A Randomized Clinical Trial

Importance Postoperative recurrence remains a major challenge after primary pterygium surgery, and whether grafting approaches are more effective than intraoperative mitomycin C (MMC) in reducing recurrence remains uncertain. Objective To determine whether grafting with conjunctival autograft (CAG) or amniotic membrane transplant (AMT) is superior to MMC in preventing 1-year recurrence after primary pterygium excision. Design, Setting, and Participants This multicenter, open-label randomized clinical trial with masked outcome assessment with 12-month follow-up was conducted at 5 tertiary hospitals in China. Enrollment and follow-up occurred between January 2016 and December 2020, and data were analyzed from September 2025 through January 2026. Patients aged 18 to 80 years with primary pterygium were enrolled and randomly assigned 1:1:1 to AMT (n = 249), MMC (n = 248), or CAG (n = 253). Interventions Standardized pterygium excision with conjunctival excision extending radially 4 mm from the limbus, combined with AMT, MMC, or CAG. Main Outcomes and Measures The primary outcome was 12-month postoperative recurrence. Secondary outcomes included best-corrected visual acuity, epithelial healing time, and conjunctival congestion scores. Results Of 750 randomized participants (mean [SD] age, 57.2 [10.5] years; 487 women [64.9%]), 681 (90.8%) completed follow-up. Recurrence in the intention-to-treat analysis was 57 participants of 249 with AMT (22.9%), 34 of 248 with MMC (13.7%), and 13 of 253 with CAG (5.0%). Risk differences were 9.2 percentage points for AMT vs MMC (98.33% CI, 0.6-17.9; P = .01), 17.9 for AMT vs CAG (98.33% CI, 10.5-25.4; P < .001), and 8.7 for MMC vs CAG (98.33% CI, 2.2-15.2; P = .001). Risk ratios were 1.69 (98.33% CI, 0.99-2.91; P = .02), 4.62 (98.33% CI, 2.14-9.97; P < .001), and 2.73 (98.33% CI, 1.20-6.20; P = .004), respectively. Complete-case analyses yielded similar results. Adverse events occurred in 18 of 249 AMT participants (7.2%), 28 of 248 MMC participants (11.3%), and 16 of 253 CAG participants (6.3%), with no intervention-related serious adverse events. Conclusions and Relevance In this randomized clinical trial, among patients undergoing primary pterygium excision, recurrence was lowest with CAG, intermediate with MMC, and highest with AMT. The moderate magnitude of the between-procedure differences makes recurrence prevention an important—but not exclusive—determinant of surgical choice and may inform individualized surgical management. Trial Registration ClinicalTrials.gov Identifier: NCT02102776

Authors

Institutions

Publication Details

Journal
JAMA Ophthalmology
Published
2026-11-19
DOI
https://doi.org/10.1001/jamaophthalmol.2026.5279
Primary Topic
Corneal Surgery and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Grafting vs Intraoperative Mitomycin C for Preventing Pterygium Recurrence: A Randomized Clinical Trial

Wenyan Peng, Wen-Rui Deng, Fu-tian Luo, Hai-feng Zhu et al.
JAMA Ophthalmology
Corneal Surgery and Treatments
article

Grafting vs Intraoperative Mitomycin C for Preventing Pterygium Recurrence: A Randomized Clinical Trial

Wenyan Peng, Wen-Rui Deng, Fu-tian Luo, Hai-feng Zhu, Lei Zhu, Ling Jin, Shi-you Zhou, Hai Liu, Chun-xiao Wang, Li Luo
article en

Abstract

Importance Postoperative recurrence remains a major challenge after primary pterygium surgery, and whether grafting approaches are more effective than intraoperative mitomycin C (MMC) in reducing recurrence remains uncertain. Objective To determine whether grafting with conjunctival autograft (CAG) or amniotic membrane transplant (AMT) is superior to MMC in preventing 1-year recurrence after primary pterygium excision. Design, Setting, and Participants This multicenter, open-label randomized clinical trial with masked outcome assessment with 12-month follow-up was conducted at 5 tertiary hospitals in China. Enrollment and follow-up occurred between January 2016 and December 2020, and data were analyzed from September 2025 through January 2026. Patients aged 18 to 80 years with primary pterygium were enrolled and randomly assigned 1:1:1 to AMT (n = 249), MMC (n = 248), or CAG (n = 253). Interventions Standardized pterygium excision with conjunctival excision extending radially 4 mm from the limbus, combined with AMT, MMC, or CAG. Main Outcomes and Measures The primary outcome was 12-month postoperative recurrence. Secondary outcomes included best-corrected visual acuity, epithelial healing time, and conjunctival congestion scores. Results Of 750 randomized participants (mean [SD] age, 57.2 [10.5] years; 487 women [64.9%]), 681 (90.8%) completed follow-up. Recurrence in the intention-to-treat analysis was 57 participants of 249 with AMT (22.9%), 34 of 248 with MMC (13.7%), and 13 of 253 with CAG (5.0%). Risk differences were 9.2 percentage points for AMT vs MMC (98.33% CI, 0.6-17.9; P = .01), 17.9 for AMT vs CAG (98.33% CI, 10.5-25.4; P < .001), and 8.7 for MMC vs CAG (98.33% CI, 2.2-15.2; P = .001). Risk ratios were 1.69 (98.33% CI, 0.99-2.91; P = .02), 4.62 (98.33% CI, 2.14-9.97; P < .001), and 2.73 (98.33% CI, 1.20-6.20; P = .004), respectively. Complete-case analyses yielded similar results. Adverse events occurred in 18 of 249 AMT participants (7.2%), 28 of 248 MMC participants (11.3%), and 16 of 253 CAG participants (6.3%), with no intervention-related serious adverse events. Conclusions and Relevance In this randomized clinical trial, among patients undergoing primary pterygium excision, recurrence was lowest with CAG, intermediate with MMC, and highest with AMT. The moderate magnitude of the between-procedure differences makes recurrence prevention an important—but not exclusive—determinant of surgical choice and may inform individualized surgical management. Trial Registration ClinicalTrials.gov Identifier: NCT02102776

JAMA Ophthalmology
Sun Yat-sen University (CN), Yunnan University (CN), Southern University of Science and Technology (CN), Northwest University (CN), West China Hospital of Sichuan University (CN), First People's Hospital of Foshan (CN), Henan Provincial Eye Hospital (CN), State Key Laboratory of Ophthalmology (CN), Northwest University First Hospital (CN), Zhongshan Ophthalmic Center, Sun Yat-sen University (CN)
Corneal Surgery and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon